Quality of life in patients with neovascular age-related macular degeneration before and after intravitreal therapy: a longitudinal observational study - Takeaways - MDSpire

Quality of life in patients with neovascular age-related macular degeneration before and after intravitreal therapy: a longitudinal observational study

  • By

  • Marta Nowak

  • Anna Maria Cybulska

  • Aleksandra Derezińska

  • Elżbieta Grochans

  • Mariusz Panczyk

  • Katarzyna Kęcka

  • Kamila Rachubińska

  • May 29, 2026

  • 0 min

Share

  • 1

    Neovascular age-related macular degeneration significantly impairs quality of life, particularly in individuals over 50.

  • 2

    Intravitreal injections are the gold standard treatment for neovascular AMD, aiming to improve vision-related quality of life.

  • 3

    A study of 121 patients showed significant improvement in vision-related quality of life after seven intravitreal injections.

  • 4

    Better visual acuity and contrast sensitivity were associated with higher quality of life scores in patients with neovascular AMD.

  • 5

    The findings support the psychosocial benefits of intravitreal therapy, encouraging patient adherence to treatment.

Original Source(s)

Quality of life in patients with neovascular age-related macular degeneration before and after intravitreal therapy: a longitudinal observational study

  • by Marta Nowak, Anna Maria Cybulska, Aleksandra Derezińska, Elżbieta Grochans, Mariusz Panczyk, Katarzyna Kęcka, Kamila Rachubińska

  • May 29, 2026

Related Content

Safety signals of perfluorohexyloctane ophthalmic solution in patients with dry eye disease

From Babylon to Berlin

Iraqi-born ophthalmologist Hasan Chichan reflects on bridging the divide between modern retina care and humanitarian medicine

Neovascular glaucoma: pathophysiology, diagnosis, and contemporary management